Related Experiment Video
Updated: Jul 22, 2025

08:02
In Vivo Augmentation of Gut-Homing Regulatory T Cell Induction
Published on: January 22, 2020
5.5K
The vitamin B5/coenzyme A axis: A target for immunomodulation?
Richard Miallot1, Virginie Millet1, Franck Galland1
1CIML, Marseille, France.
European Journal of Immunology
|July 24, 2023
Summary
Coenzyme A (CoA) metabolism impacts energy, lipids, and immunity. Regulating its precursor, Vitamin B5, may treat chronic diseases and enhance anti-tumor responses.
Area of Science:
- Biochemistry
- Immunology
- Metabolic pathways
Background:
- Coenzyme A (CoA) is essential for energy production, lipid metabolism, and biosynthesis.
- Dysregulated CoA pathways are linked to chronic diseases like inflammation, obesity, diabetes, cancer, and cardiovascular disorders.
- CoA modulates immune cell activation, proliferation, differentiation, and effector functions.
Purpose of the Study:
- To review the role of CoA metabolism in chronic diseases and immune function.
- To focus on Vitamin B5/pantothenate's role in regulating CoA availability.
- To explore therapeutic potential targeting CoA metabolism for Th17-mediated inflammation, CD8-mediated anti-tumor immunity, and tissue repair.
Main Methods:
- Literature review of CoA metabolism and its role in disease.
- Analysis of pathways regulating pantothenate (Vitamin B5) availability.
- Examination of CoA's impact on immune cell subsets (Th17, CD8) and tissue repair.
Main Results:
- CoA dysregulation contributes to various chronic inflammatory and degenerative diseases.
- Pantothenate availability is a key regulator of CoA levels in vivo.
- Modulating CoA metabolism shows therapeutic promise for immune-mediated diseases and cancer.
Conclusions:
- Targeting CoA metabolism, particularly Vitamin B5 pathways, offers a potential therapeutic strategy.
- Restoring metabolic balance via CoA modulation may mitigate chronic inflammation and enhance anti-tumor immunity.
- This approach could improve outcomes for patients with chronic inflammatory, degenerative, and neoplastic diseases.
Related Concept Videos
B Cell Activation and Differentiation
1.8K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
1.8K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
195
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
195
Immune Response Against Viral Pathogens
826
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
826
Cytotoxic T Cells-mediated Immune Response
977
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
977
Tumor Immunotherapy
560
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
560
Immunodeficiency Diseases
979
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
There are three main causes of immunodeficiency...
979

